Background: Most studies that attempt to clarify structural abnormalities related to functional disconnection in patients with Alzheimer's disease (AD) have focused on exploring pathological changes in cortical gray matter. However, white matter fibers connecting these cerebral areas may also be abnormal. Purpose: To investigate the regional changes of white matter volume in patients with AD compared to healthy subjects. Material and Methods: White matter volume changes in whole-brain magnetic resonance images acquired from 19 patients with AD and 20 healthy subjects (control group) were observed using the optimized voxel-based morphometry (VBM) method. In addition, the corpus callosum (CC) of AD patients and the control group wa...
Background: Positron emission tomographic studies of patients with Alzheimer disease (AD) suggest a ...
This study investigates abnormalities of grey (GM) and white matter (WM) in Alzheimer's disease (AD)...
This study investigates abnormalities of grey (GM) and white matter (WM) in Alzheimer's disease (AD)...
An increasing number of MRI investigations suggest that patients with Alzheimer's disease (AD) show ...
Alzheimers disease (AD) represents the most prevalent neurodegenerative disorder that causes cogniti...
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Current avenues of...
Regional cortical atrophy in Alzheimer’s disease (AD) most likely reflects the loss of cortical neur...
Tractography based on Diffusion Tensor Imaging (DTI) represents a valuable tool for investigating br...
AimThis study aims to assess the integrity of white matter in various segments of the corpus callosu...
BACKGROUND: The corpus callosum (CC) has been shown to be susceptible to atrophy in Alzheimer di...
BACKGROUND: The corpus callosum (CC) has been shown to be susceptible to atrophy in Alzheimer di...
AimThis study aims to assess the integrity of white matter in various segments of the corpus callosu...
BACKGROUND: The corpus callosum (CC) has been shown to be susceptible to atrophy in Alzheimer di...
Voxel-based morphometry (VBM) has already been applied to MRI scans of patients with Alzheimer's dis...
AimThis study aims to assess the integrity of white matter in various segments of the corpus callosu...
Background: Positron emission tomographic studies of patients with Alzheimer disease (AD) suggest a ...
This study investigates abnormalities of grey (GM) and white matter (WM) in Alzheimer's disease (AD)...
This study investigates abnormalities of grey (GM) and white matter (WM) in Alzheimer's disease (AD)...
An increasing number of MRI investigations suggest that patients with Alzheimer's disease (AD) show ...
Alzheimers disease (AD) represents the most prevalent neurodegenerative disorder that causes cogniti...
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Current avenues of...
Regional cortical atrophy in Alzheimer’s disease (AD) most likely reflects the loss of cortical neur...
Tractography based on Diffusion Tensor Imaging (DTI) represents a valuable tool for investigating br...
AimThis study aims to assess the integrity of white matter in various segments of the corpus callosu...
BACKGROUND: The corpus callosum (CC) has been shown to be susceptible to atrophy in Alzheimer di...
BACKGROUND: The corpus callosum (CC) has been shown to be susceptible to atrophy in Alzheimer di...
AimThis study aims to assess the integrity of white matter in various segments of the corpus callosu...
BACKGROUND: The corpus callosum (CC) has been shown to be susceptible to atrophy in Alzheimer di...
Voxel-based morphometry (VBM) has already been applied to MRI scans of patients with Alzheimer's dis...
AimThis study aims to assess the integrity of white matter in various segments of the corpus callosu...
Background: Positron emission tomographic studies of patients with Alzheimer disease (AD) suggest a ...
This study investigates abnormalities of grey (GM) and white matter (WM) in Alzheimer's disease (AD)...
This study investigates abnormalities of grey (GM) and white matter (WM) in Alzheimer's disease (AD)...